Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT01888562
Title Ponatinib in the Treatment of FGFR Mutation Positive Recurrent or Persistent Endometrial Carcinoma
Recruitment Withdrawn
Gender female
Phase Phase I
Variant Requirements Yes
Sponsors Washington University School of Medicine
Age Groups: adult
Covered Countries

Additional content available in CKB BOOST